Failure to find linkage between schizophrenia and genetic markers on chromosome 21.
We sought evidence for the involvement of mutations in the amyloid precursor protein gene (APP) in the pathogenesis of schizophrenia in two ways. First, linkage analysis was performed in a sample of 24 families multiply affected with schizophrenia. The genotypes were studied for GT12 (D21S210), a highly polymorphic microsatellite marker at the APP locus. Second, we used single strand conformation analysis (SSCA) to screen for mutations in exon 17 of APP in one affected member from each family and in a sample of 44 unrelated patients. In addition, we looked for linkage between schizophrenia and a series of highly polymorphic markers situated at approximately 20cM intervals along the long arm of chromosome 21. We were unable to find evidence for linkage to GT12 or the other markers studied. SSCA did not reveal any mutations in exon 17 of AP. We conclude that mutations within APP are an unlikely cause of schizophrenia. Moreover, this study provides no evidence for a major gene for schizophrenia on chromosome 21, and linkage can be excluded from much of this region under some genetic models.
Asherson
P
P
Department of Psychological Medicine, University of Wales College of Medicine, Heath Park, Cardiff.
Mant
R
R
Taylor
C
C
Sargeant
M
M
Collier
D
D
Clements
A
A
Nanko
S
S
Whatley
S
S
Gill
M
M
McGuffin
P
P
D000328:Adult; D000368:Aged; D016564:Amyloid beta-Protein Precursor / Q000235:genetics*; D002891:Chromosomes, Human, Pair 21; D005260:Female; D008040:Genetic Linkage; D005819:Genetic Markers; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation; D012559:Schizophrenia / Q000235:genetics*
D016564:Amyloid beta-Protein Precursor; D005819:Genetic Markers